Pharmaceutics

Pharmacology, Toxicology and Pharmaceutical Science

1. Acetic Acid Ethyl Ester 13%
2. Anti-Inflammatory Drug 48%
3. Antibacterial Activity 19%
4. Antibiotics 14%
5. Antidiabetic Agent 9%
6. Antiinfective Agent 61%
7. Antiinflammatory Activity 9%
8. Antimicrobial Agent 20%
9. Antimicrobial Resistance 8%
10. Antioxidant 54%
11. Antioxidant Capacity 19%
12. Antivirus Agent 10%
13. Apigenin 10%
14. Apremilast 11%
15. Ascorbic Acid 9%
16. Atopic Dermatitis 8%
17. Baricitinib 9%
18. Bioavailability 74%
19. Biological Activity 7%
20. Biological Marker 15%
21. Breast Cancer 39%
22. Carbon Dioxide 11%
23. Caspase 3 8%
24. Chitosan 36%
25. Clinical Trial 9%
26. Combination Therapy 17%
27. Curcumin 9%
28. Cyclodextrin 12%
29. Cytokine 16%
30. Cytotoxicity 47%
31. Delafloxacin 11%
32. Diabetes Mellitus 11%
33. Diethylene Glycol Monoethyl Ether 9%
34. Differential Scanning Calorimetry 20%
35. Diosmin 11%
36. Diseases 37%
37. Dosage Form 8%
38. Drug Delivery System 35%
39. Drug Development 8%
40. Drug Release 39%
41. Drug Solubility 9%
42. Essential Oil 20%
43. Ethyl Cellulose 9%
44. Eudragit 8%
45. Flavonoid 11%
46. Gallic Acid 9%
47. Glycyrrhizin 8%
48. Gold Nanoparticle 14%
49. High Performance Liquid Chromatography 17%
50. IC50 17%
51. Infection 22%
52. Infectious Agent 11%
53. Inflammation 31%
54. Inflammatory Arthritis 9%
55. Interleukin 6 14%
56. Liposome 11%
57. Lung Cancer 20%
58. Malignant Neoplasm 58%
59. Metformin 9%
60. Methanol 12%
61. Methicillin-Resistant Staphylococcus Aureus 15%
62. microRNA 11%
63. Mole (Insectivora) 7%
64. Nanocarrier 33%
65. Nanoemulsion 32%
66. Nanogel 14%
67. Nanoparticle 100%
68. Natural Product 13%
69. Neoplasm 16%
70. Nephrotoxicity 8%
71. Non Small Cell Lung Cancer 10%
72. Parkinson's Disease 14%
73. Pharmacodynamics 8%
74. Pharmacokinetic 52%
75. Phytochemical 26%
76. Poloxamer 17%
77. Polyglactin 10%
78. Polyvinyl Alcohol 9%
79. Propylene Glycol 7%
80. Pseudomonas aeruginosa 16%
81. Psoriasis 23%
82. Rat Model 13%
83. Receptor 16%
84. Reverse Phase High Performance Liquid Chromatography 8%
85. Rheumatoid Arthritis 9%
86. Rutin 10%
87. Scanning Electron Microscopy 20%
88. Silver Nanoparticle 8%
89. Silymarin 10%
90. Simvastatin 10%
91. Skin Infection 9%
92. Solid Lipid Nanoparticle 19%
93. Staphylococcus aureus 15%
94. Surfactant 11%
95. Sustained Release 29%
96. Tablet 35%
97. Tumor Necrosis Factor 14%
98. Untranslated RNA 13%
99. Wound Healing 20%
100. Zeta Potential 35%